Back
Summit Therapeutics Stock Price Chart
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free
Sell
46
SMMT
Summit Therapeutics
Last Price:
$16.66
Seasonality Move:
7.78%
7 Day Trial
ALL ACCESS PASS
$
7
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Summit Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.11 | Buy |
| 20-day SMA: | 18.21 | Sell |
| 50-day SMA: | 18.8 | Sell |
| 200-day SMA: | 12.96 | Buy |
| 8-day EMA: | 18.17 | Buy |
| 20-day EMA: | 18.28 | Sell |
| 50-day EMA: | 18.54 | Sell |
| 200-day EMA: | 14.22 | Buy |
Summit Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 48.68 | Sell |
| Chaikin Money Flow: | 1356879 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.7 - 18.74) | Sell |
| Bollinger Bands (100): | (15.6 - 22.64) | Sell |
Summit Therapeutics Technical Analysis
| Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 18.18 while SMMT 8-day simple moving average is 18.11, which is a Buy signal.
-
The stock price of SMMT is 18.18 while Summit Therapeutics 20-day SMA is 18.21, which makes it a Sell.
-
Summit Therapeutics 50-day simple moving average is 18.80 while SMMT share price is 18.18, making it a Sell technically.
-
SMMT stock price is 18.18 and Summit Therapeutics 200-day simple moving average is 12.96, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Sell
46
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a SellThe current Summit Therapeutics [SMMT] share price is $18.18. The Score for SMMT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Summit Therapeutics Stock Info
Market Cap:
13.4B
Price in USD:
18.18
Share Volume:
1.7M
Summit Therapeutics 52-Week Range
52-Week High:
33.89
52-Week Low:
2.10
Sell
46
Summit Therapeutics (SMMT)
is a Sell
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?The Summit Therapeutics stock price is 18.18 USD today.
-
Will SMMT stock go up or go down?Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Summit Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is overvalued.
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 18.18 while SMMT 8-day exponential moving average is 18.17, which is a Buy signal.
-
The stock price of SMMT is 18.18 while Summit Therapeutics 20-day EMA is 18.28, which makes it a Sell.
-
Summit Therapeutics 50-day exponential moving average is 18.54 while SMMT share price is 18.18, making it a Sell technically.
-
SMMT stock price is 18.18 and Summit Therapeutics 200-day simple moving average is 14.22, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.16 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
-
SMMT Moving Average Covergence Divergence (MACD) indicator is -0.17, suggesting Summit Therapeutics is a Sell
-
Summit Therapeutics Relative Strength Index (RSI) is 48.68, which suggest Summit Therapeutics is oversold
-
The Bollinger Bands (25) for Summit Therapeutics is (17.7 - 18.74), which suggest Summit Therapeutics is a Sell
-
The Bollinger Bands (100) for Summit Therapeutics is (15.6 - 22.64), which suggest Summit Therapeutics is a Sell
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.